Synlett 2016; 27(11): 1669-1673
DOI: 10.1055/s-0035-1561429
letter
© Georg Thieme Verlag Stuttgart · New York

An Unexpected Diastereoselective Synthesis of Novel Substituted Pyridines via One-Pot, Four-Component Reaction

Mahdieh Zangouei
a   Department of Chemistry, Ferdowsi University of Mashhad, Mashhad 917751436, Iran   Email: abesmaeili@um.ac.ir
,
Abbas Ali Esmaeili*
a   Department of Chemistry, Ferdowsi University of Mashhad, Mashhad 917751436, Iran   Email: abesmaeili@um.ac.ir
,
Joel T. Mague
b   Department of Chemistry, Tulane University, New Orleans, LA 70118, USA
› Author Affiliations
Further Information

Publication History

Received: 19 January 2016

Accepted after revision: 18 March 2016

Publication Date:
13 April 2016 (online)


Abstract

An efficient diastereoselective approach for the preparation of novel substituted pyridines has been developed through a one-pot, four-component reaction of easily available aromatic aldehydes, malononitrile, and 6,8-dimethyl-2-hydroxy-4H-pyrimido[1,2-a]pyrimidine-4-one, in appropriate alcohols at reflux in the presence of diisopropylethylamine (DIPEA) as organic base catalyst. Unexpected products were obtained in high to excellent yields using a simple workup procedure. The products synthesized showed high diastereoselectivity, and the stereochemistry was confirmed by X-ray diffraction analysis.

Supporting Information

 
  • References and Notes

    • 1a Multicomponent Reactions. Zhu J, Bienayme H. Weinheim: Wiley-VCH; 2005
    • 1b Bienayme H, Hulme C, Oddon G, Schmitt P. Chem. Eur. J. 2000; 6: 3321
    • 1c Dömling A, Ugi I. Angew. Chem. Int. Ed. 2000; 39: 3168
    • 1d Guo X, Hu W. Acc. Chem. Res. 2013; 46: 2427
    • 2a Rostom SA, Ashour HM, Abd E, Razik HA. Arch. Pharm. 2009; 342: 299
    • 2b El-Deeb IM, Lee SH. Bioorg. Med. Chem. 2010; 18: 3860
  • 3 Gahlot US, Rao SS, Dulawat SS, Ameta KL, Verma BL. Afinidad 2003; 60: 558
    • 4a Yit CC, Das NP. Cancer Lett. 1994; 82: 65
    • 4b Jiang BC, Yang G, Xiong WN, Wang J. Bioorg. Med. Chem. 2001; 9: 1149
  • 5 Nofal AM, Fahmy HH, Zarea ES, El-Eraky W. Acta Pol. Pharm. 2011; 68: 507
  • 6 Badshaw TD, Wrigley S, Shi DF, Schultz RJ, Paull KD, Stevens MF. G. Br. J. Cancer 1998; 77: 745
    • 7a Kompis IM, Islam K, Then LK. Chem. Rev. 2005; 105: 593
    • 7b Martins MA. P, Cunico W, Pereira CM. P, Flores AF. C, Bonacorso HG, Zanatta N. Curr. Org. Synth. 2004; 1: 391
    • 8a Cocco MT, Congiu C, Onnis V. Eur. J. Med. Chem. 2003; 38: 37
    • 8b Cocco MT, Congiu C, Onnis V. Eur. J. Med. Chem. 2000; 35: 545
  • 9 Storck P, Aubertinb AM, Grierson DS. Tetrahedron Lett. 2005; 46: 2919
    • 10a Breinholt J, Ludvigesen S, Rassing BR, Rosendahl CN. J. Nat. Prod. 1997; 60: 33
    • 10b Singh SB, Liu W, Li X, Chen T, Shafiee A, Card D, Abruzzo G, Flattery A, Gill C, Thompson JR, Rosenbach M, Dreikorn S, Hornak V, Meinz M, Kurtz M, Kelly R, Onishi JC. ACS Med. Chem. Lett. 2012; 3: 814
  • 11 Lv Z, Sheng C, Wang T, Zhang Y, Liu J, Feng J, Sun H, Zhong H, Niu C, Li K. J. Med. Chem. 2010; 53: 660
  • 12 Wallace EM, Lyssikatos J, Blake JF, Seo J, Yang HW, Yeh TC, Perrier M, Jarski H, Marsh V, Poch G, Livingston MG, Otten J, Hingorani G, Woessner R, Lee P, Winkler J, Koch K. J. Med. Chem. 2006; 49: 441
  • 13 Hu E, Tasker A, White RD, Kunz RK, Human J, Chen N, Burli R, Hungate R, Novak P, Itano A, Zhang X, Yu V, Nguyen Y, Tudor Y, Plant M, Flynn S, Xu Y, Meagher KL, Whittington DA, Ng GY. J. Med. Chem. 2008; 51: 3065
  • 14 Dragovich PS, Prins TJ, Zhou R, Johnson TO, Hua Y, Luu HT, Sakata SK, Brown EL, Maldonado FC, Tuntland T, Lee CA, Fuhrman SA, Zalman LS, Patick AK, Matthews DA, Wu EY, Guo M, Borer BC, Nayyar NK, Moran T, Chen L, Rejto PA, Rose PW, Guzman MC, Dovalsantos EZ, Lee S, McGee K, Mohajeri M, Liese A, Tao J, Kosa MB, Liu B, Batugo MR, Gleeson JP. R, Wu ZP, Liu J, Meador JW, Ferre RA. J. Med. Chem. 2003; 46: 4572
  • 15 Li R, Xue L, Zhu T, Jiang Q, Cui X, Yan Z, McGee D, Wang J, Gantla VR, Pickens JC, McGrath D, Chucholowski A, Morris SW, Webb TR. J. Med. Chem. 2006; 49: 1006
  • 16 Lenaerts AJ, Bitting C, Woolhiser L, Gruppo V, Marietta KS, Johnson CM, Orme IM. Antimicrob. Agents Chemother. 2008; 52: 1513
  • 17 Cheney IW, Yan S, Appleby T, Walker H, Vo T, Yao N, Hamatake Hong RZ, Wu JZ. Bioorg. Med. Chem. Lett. 2007; 17: 1679
    • 18a Du W. Tetrahedron 2003; 59: 8649
    • 18b Ravinder M, Mahendar B, Mattapally S, Hamsini KV, Reddy TN, Rohit C, Srinivas K, Banerjee K, Rao VJ. Bioorg. Med. Chem. Lett. 2012; 22: 6010
    • 18c Pfefferkorn JA, Lou J, Minich ML, Filipski KJ, He M, Zhou R, Ahmed S, Benbow J, Perez A, Tu M, Litchfield J, Sharma R, Metzler K, Bourbonais F, Huang C, Beebe DA, Oates PJ. Bioorg. Med. Chem. Lett. 2009; 19: 3247
    • 18d Cinelli MA, Morrell A, Dexheimer TS, Scher ES, Pommier Y, Cushmann M. J. Med. Chem. 2008; 51 4609
    • 18e Chen J, Lu MM, Liu B, Chen Z, Li QB, Tao LJ, Hu GY. Bioorg. Med. Chem. Lett. 2012; 22: 2300
    • 18f Nakao Y, Idei H, Kanyiva KS, Hiyama T. J. Am. Chem. Soc. 2009; 131: 15996
  • 19 Gadekar SM. DE 2555411, 1976 ; Chem. Abstr. 1976, 85, 198163b
    • 20a Ehteshami M, Scarth BJ, Tchesnokov EP, Dash C, Le Grice SF. J, Hallenberger S, Jochmans D, Götte M. J. Biol. Chem. 2008; 283: 29904
    • 20b Ehteshami M, Nijhuis M, Bernatchez JA, Ablenas CJ, McCormick S, Jong DD, Jochmans D, Götte M. J. Biol. Chem. 2013; 28: 17336
    • 20c Jochmans DE. D, Wigerinck PT. B. P. WO 2007088214, 2007 ; Chem. Abstr. 2007, 147, 227136
    • 20d Sarkar R, Mukhopadhyay C. Tetrahedron Lett. 2014; 55: 2618
  • 21 Ferraz AC, Angelucci ME. M, Da Costa ML, Batista IR, De Olivera BH, Da Cunha C. Pharmacol. Biochem. Behav. 1999; 63: 367
  • 22 Kheder NA, Mabkhot YN, Farag AM. Synth. Commun. 2008; 38: 3170
    • 23a Zangouei M, Esmaeili AA, Habibi A, Fakhari AR. Tetrahedron 2014; 70: 8619
    • 23b Esmaeili AA, Amini-Ghalandarabad S, Mesbah F, Tasmimi M, Izadyar M, Fakhari AR, Salimi AR. Tetrahedron 2015; 71: 2458
    • 23c Esmaeili AA, Salehan F, Habibi A, Fakhari AR. Tetrahedron Lett. 2015; 57: 100
    • 23d Esmaeili AA, Zangouei M, Fakhari AR, Habibi A. Tetrahedron Lett. 2012; 53: 1351
  • 24 Güllü M, Dinçsönmez A, Özyavaş Ö. Eur. J. Org. Chem. 2010; 2113
  • 25 General Procedure for the Synthesis of 4 A mixture of aromatic aldehyde (1, 1 mmol), malononitrile (2, 1 mmol, 660 mg), 6,8-dimethyl-2-hydroxy-4H-pyrimido[1,2-a]pyrimidin-4-one (3, 1 mmol, 192 mg), and DIPEA (5 mol%) was heated to reflux in the requisite alcohol (6 mL) for 2 h (the progress of the reaction was monitored by TLC). After completion of reaction, the mixture was allowed to cool to room temperature, and the precipitate was filtered off and washed with cold alcohol to afford the pure alkyl 6-amino-5-cyano-2-oxo-4-phenyl-1-pyrimidin-2-yl-1,2,3,4-tetrahydropyridine-3-carboxylate 4 (yields 85–95%). Representative Analytical Data Ethyl 6-Amino-5-cyano-1-(4,6-dimethylpyrimidin-2-yl)-2-oxo-4-phenyl-1,2,3,4-tetrahydropyridine-3-carboxylate (4a) White powder, 355 mg (91%); mp 207 °C; Rf = 0.52 (n-hexane–EtOAc, 1:1.5). IR (KBr): ν = 3448, 3324 (NH2), 2195 (CN), 1743, 1721 (2 C=O), 1653 (C=N) cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.19 (t, 3 H, J = 7.0 Hz,OCH2CH 3), 2.54 (s, 6 H, 2 CH3), 3.85 (d, 1 H, J = 7.7 Hz, CHC=O), 4.15–4.20 (m, 2 H, OCH 2CH3), 4.34 (d, 1 H, J = 7.7 Hz, CHAr), 4.91 (s, 2 H, NH2), 7.10 (s, 1 H, CH=CCH3), 7.26–7.38 (m, 5 H, HAr). 13C NMR (75 MHz, CDCl3): δ = 13.98 (OCH2 CH3), 23.84 (2 CH3), 40.28 (CHPh), 56.64 (CHC=O), 62.02 (CCN), 63.41 (CH2O), 119.16 (C≡N), 120.42 (CHAr), 127.65 (2 CH ortho ), 128.04 (CH para ), 129.02 (2 CH meta ), 138.38 (CAr), 152.20 (CNH2), 155.16 (NC=N), 165.43 (C=O), 167.05 (C=O), 170.07 (2 CCH3). MS: m/z (%) = 391 (4) [M+], 378 (69), 358 (64), 341 (18), 313 (100), 258 (68), 271 (63), 233 (62). 211 (48), 198 (63), 164 (65), 122 (66), 106 (71), 81 (61), 67 (70), 42 (64), 29 (65). Anal. Calcd for C21H21N5O3: C, 64.44; H, 5.41; N, 17.89. Found: C, 63.99; H, 5.39; N, 17.83. Ethyl 6-Amino-5-cyano-1-(4,6-dimethylpyrimidine-2-yl)-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3-carboxylate(4b) White powder, 409 mg (94%); mp 211–212 °C; Rf = 0.40 (n-hexane–EtOAc, 1:1.5). IR (KBr): ν = 3452, 3350 (NH2), 2185 (CN), 1747, 1717 (2 C=O), 1632 (C=N) cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.24 (t, 3 H, J = 4.5 Hz, OCH2CH 3), 2.56 (s, 6 H, 2 CH3), 3.82 (d, 1 H, J = 7.79 Hz, CHC=O), 4.21–4.25 (m, 2 H, OCH 2CH3), 4.46 (d, 1 H, J = 7.79 Hz, CHAr), 5.11 (s, 2 H, NH2), 7.12 (s, 1 H, CH=CCH3), 7.26–8.31 (m, 4 H, HAr). 13C NMR (75 MHz, CDCl3): δ = 14.02 (OCH2 CH3), 23.81 (2 CH3), 40.15 (CHPh), 56.51 (CHC=O), 61.25 (CCN), 62.50 (CH2O), 118.81 (C≡N), 120.60 (CHAr), 122.74 (CH ortho ), 123.244 (CH para ), 130.16 (CH meta ), 134.12 (CH ortho ), 140.83 (NC=N), 148.69 (CAr), 153.05 (CNH2), 154.99 (CNO2), 164.60 (C=O), 166.48 (C=O), 170.27 (2 CCH3). MS: m/z (%) = 436 (14) [M+], 422 (72), 393 (71), 346 (100), 318 (71), 304 (69), 241 (42), 212 (32), 199 (72), 150 (71), 123 (73), 107 (74), 82 (50), 67 (72), 29 (74). Anal. Calcd for C21H20N6O5: C, 57.79; H, 4.62; N, 17.26. Found: C, 57.62; H, 4.27; N, 16.95.